Improving the Diagnosis and Management of Neuroendocrine Tumors: Utilizing New Advances in Biomarker and Molecular Imaging Science

Publisher： Karger

E-ISSN： 1423-0194|98|1|16-30

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.98, Iss.1, 2013-06, pp. : 16-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of Cross-Sectional and Molecular Imaging Studies in the Localization of Gastroenteropancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 99, Iss. 2, 2014-01 ,pp. : 63-74

Karger

Access to resources Recommend Favorite

Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients

By  

Neuroendocrinology, Vol. 95, Iss. 4, 2012-02 ,pp. : 344-350

Karger

Access to resources Recommend Favorite

Translation of Molecular Pathways into Clinical Trials of Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-04 ,pp. : 99-112

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification

By  

Neuroendocrinology, Vol. 90, Iss. 2, 2008-12 ,pp. : 162-166

Karger

Access to resources Recommend Favorite

The German NET-Registry: An Audit on the Diagnosis and Therapy of Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 90, Iss. 4, 2009-09 ,pp. : 349-363

Karger

Access to resources Recommend Favorite